Document is current
Any future updates will be listed below
-
Authors
Baker, Sarah M. https://orcid.org/0000-0002-0177-8135
Settles, Erik W. https://orcid.org/0000-0003-4331-3683
Celona, Kimberly R.
Shannon, Austin B. https://orcid.org/0000-0002-7601-253X
Davitt, Christpher
Hall, Kalen
Jain, Aarti
de Assis, Rafael R.
Gregory, Anthony E. https://orcid.org/0000-0001-5540-1256
Felgner, Philip L.
Woerle, Celeste
Mayo, Mark
Currie, Bart J. https://orcid.org/0000-0002-8878-8837
Wimley, William C.
McLachlan, James B. https://orcid.org/0000-0001-7741-391X
Yoon, Heesik
Dao, Chinh T.
Moser, Janice
Pociask, Derek https://orcid.org/0000-0002-1256-6410
Keim, Paul https://orcid.org/0000-0003-0089-5820
Russell-Lodrigue, Kasi https://orcid.org/0000-0003-3719-0779
Roy, Chad J. https://orcid.org/0000-0002-1710-6974
Morici, Lisa A. https://orcid.org/0000-0002-4799-4941
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 25 November 2025
First Online: 9 December 2025
Competing interests
: J.B.M. and L.A.M. are inventors of the O.M.V. vaccine and have a U.S. Provisional Application No.: 63/554,522 filed. H. Yoon, C. Dao, and J. Moser are/were Sanofi employees and may hold shares and/or stock options in the company. The remaining authors declare no competing interests.
